Cosmos Health Inc. Cash Flow Statement
COSM|13 years of annual SEC 10-K data (FY2013-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 13 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
-$8M
FY2025
Free Cash Flow
-$9M
FY2025
Capital Expenditures
$55,675
Cash used for long-term assets
Dividends Paid
N/A
FY2025
Cosmos Health Inc. used $8M in operating cash flow and negative free cash flow of $9M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
- Conservative debt: Debt-to-equity ratio of 0.20
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$19.1M | -$16.2M | -$18.5M | -$13.8M | -$8.0M | $820.8K | -$3.3M | -$9.1M | -$601.0K | -$6.7M | -$6.7M | $6.0M | -$455 |
| Depreciation & Amortization | $1.4M | $1.2M | $614.4K | $103.2K | $352.4K | $397.6K | $394.6K | $43.9K | $9.4K | $5.4K | - | - | - |
| Operating Cash Flow | -$8.4M | -$7.7M | -$15.6M | -$14.9M | -$7.1M | -$11.5M | -$4.8M | -$1.6M | -$2.1M | -$497.1K | -$497.1K | $6.5M | $31 |
| Capital Expenditures | $55.7K | $418.1K | $1.3M | $74.2K | $581.4K | $117.7K | - | $503.4K | $12.8K | $12.8K | $44.0K | $21.5K | - |
| Free Cash Flow | -$8.5M | -$8.1M | -$16.9M | -$14.9M | -$7.7M | -$11.6M | - | -$2.1M | -$2.1M | -$509.9K | -$541.0K | $6.5M | - |
| Share Buybacks | - | $0 | $100.5K | - | $376.9K | $200.0K | - | - | - | - | - | - | - |
| FCF Margin | -13.0% | -14.9% | -31.8% | -29.7% | -13.7% | -21.0% | - | -5.5% | -31.7% | -95.5% | -101.4% | 85.1% | - |